Amgen Announces Top-Line Results From Phase 3 KYPROLIS® (Carfilzomib) CLARION Study In Newly Diagnosed Multiple Myeloma Patients Tuesday,... ...https://www.pharmafocusasia.com/pressreleases/amgen-announces-top-line-results-from-phase-3-kyprolis-carfilzomib-clarion-study-in-newly-diagnosed-multiple-myeloma-patients
THOUSAND OAKS, Calif. , Sept.27, 2016 /PRNewswire/ -- Amgen(NASDAQ:AMGN) today announced top-line results of the Phase 3 CLARION trial, which... ...http://in.advfn.com/news_Amgen-Announces-Top-Line-Results-From-Phase-3-KYPR_72528967.html
PRWeb 2016-09-26 The webinar will discuss the clinical challenge of chronic and acute kidney injury, ProEnkephalin's role as an endogenous... ...http://www.bizwireexpress.com/showstoryPRWeb.php?storyid=546628
Kozhikode: The Kozhikode District Medical diagnostic and Para- medical cooperative society launched a Cooperative Neethi Mobile Medical lab on... ...http://www.deccanchronicle.com/lifestyle/health-and-wellbeing/260916/now-get-medical-tests-done-on-your-doorsteps.html
DUBLIN and EMERYVILLE, Calif. , Sept. 22, 2016 /PRNewswire/ -- Allergan plc (NYSE: AGN), a leading global pharmaceutical company, and Adamas... ...http://in.advfn.com/news_Allergan-and-Adamas-Announce-U-S-Availability-of_72500177.html
To give you further proof that...
Origin Research is a research and...